Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial (Q34609376)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial |
scientific article |
Statements
1 reference
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial (English)
1 reference
Robert Landewé
1 reference
Josef S Smolen
1 reference
Mahboob U Rahman
1 reference
Mittie K Doyle
1 reference
Eric L Matteson
1 reference
Jürgen Wollenhaupt
1 reference
Norman Gaylis
1 reference
Frederick T Murphy
1 reference
Jeffrey S Neal
1 reference
Yiying Zhou
1 reference
Sudha Visvanathan
1 reference
Elizabeth C Hsia
1 reference
GO-AFTER study investigators
1 reference
26 June 2009
1 reference
1 reference
374
1 reference
9685
1 reference
210-221
1 reference
Identifiers
1 reference
1 reference